Support our Foundation of Myology project
2414 news items
World Myositis Day: 21 September
On 16/09/2025
Every year since 2001, 21 September has been World Myositis Day. Myositis is an autoimmune muscle disease that can affect adults and children. It causes…
An inflammatory factor in Charcot-Marie-Tooth disease
On 16/09/2025
Two French publications suggest that an inflammatory mechanism may be involved in certain forms of Charcot-Marie-Tooth disease (CMT), which are generally considered to be exclusively…
International Myotonic Dystrophy Awareness Day
On 15/09/2025
International Myotonic Dystrophy Awareness Day takes place every year on 15 September. It aims to raise awareness on this neuromuscular disease among the medical profession,…
Review of current and emerging therapeutic strategies in DMD
On 15/09/2025
Duchenne muscular dystrophy (DMD) is a serious, progressive genetic disorder. It is caused by mutations in the DMD gene that result in the absence of…
Researchers from the Institute attending the ESGCT conference
On 15/09/2025
The 32nd Annual Meeting of the European Society for Gene & Cell Therapy (ESGCT) will be held in Seville, Spain, from 7 to 10 October…
AcadeMYO Winter School: 8-10 December 2025 online
On 14/09/2025
Join us for this unique opportunity to perfect your skills in myology, an increasingly exciting discipline dedicated to neuromuscular science! All professionals manifesting some interest…
An innovating method of molecular decoding developed to rejuvenate muscle cells
On 14/09/2025
Andrew Ho, a researcher at the Institute of Myology, is the first co-author of an article that has just been published in the June 2025…
Institute experts at the WMS 2025 Congress
On 12/09/2025
The 30th International Congress of the World Muscle Society (WMS) will be held from 7 to 11 October 2025 in Vienna, Austria. The Institute…
Only part of the D4Z4 region is necessary for epigenetic repression of DUX4
On 12/09/2025
Facioscapulohumeral muscular dystrophy (FSHD) is caused by the abnormal and delayed expression of a transcription factor called DUX4, which has a deleterious effect on adult…
Large deletions of the NEB gene in distal myopathy
On 11/09/2025
An international consortium of researchers, including two French scientists, studied possible correlations between genotype and phenotype in the context of myopathies linked to the NEB…
Towards a better understanding and management of SORD-related neuropathy
On 11/09/2025
Biallelic mutations in the SORD (sorbitol dehydrogenase) gene cause neuropathy that can present as a purely motor form (distal hereditary motor neuropathy, dHMN) or as…
Challenges remain in the design of registries for limb-girdle muscular dystrophies
On 09/09/2025
A study conducted in part by researchers at Henri Mondor Hospital in Paris reports several persistent difficulties in the design and use of registries for…
A broad genotype range for the TNNC2 gene
On 08/09/2025
French researchers report a case of neonatal hypotonia that was found to be related to a pathological sequence variant in the TNNC2 gene encoding type…
7 September: World Duchenne Awareness Day
On 07/09/2025
This year’s World Duchenne Awareness Day theme is ‘Family: At the Heart of Care’. A documentary is available on this theme, following families from around…
Improvement in cardiac and motor function with gene therapy in infantile-onset Pompe disease
On 05/09/2025
Four infants with Pompe disease received an intravenous injection of GC301, a gene therapy that delivers a codon-optimized gene encoding human acid alpha-glucosidase (GAA) carried…
Identification of CaVβ1 isoforms required in the neuromuscular junction development and maintenance
On 04/09/2025
In skeletal muscle, the voltage-gated calcium channel (VGCC) CaV1.1 enables the coupling between the electrical activity of motor neurons and muscle contraction, following stimulation of…
UK recommendations to improve orthopedic care in DMD
On 03/09/2025
A group of British experts has formulated recommendations, approved by the British Society for Children’s Orthopaedic Surgery, aimed at harmonizing and improving orthopedic care for…
A pharmacovigilance study on the use of efgartigimod in myasthenia gravis in the United States
On 03/09/2025
Efgartigimod is one of the new molecules used in refractory forms of myasthenia gravis. Chinese researchers have reviewed the side effects recorded in the Food…
Encouraging results from the ventilatory weaning protocol during myasthenic crises
On 02/09/2025
French clinicians involved in weaning myasthenic patients undergoing decompensation (myasthenic crisis) report the results of the WEAN Safe protocol applied to a single-center cohort (Paris,…
Myotonic dystrophy and increased cancer risk: the American experience
On 01/09/2025
American epidemiologists and statisticians sought to better understand the risk of developing cancer in a population with myotonic dystrophy (MD), primarily Steinert’s disease (type 1…